Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus.
about
High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coliClass II 3-hydroxy-3-methylglutaryl coenzyme A reductasesStage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation.Crystal structure of a statin bound to a class II hydroxymethylglutaryl-CoA reductaseDual Dehydrosqualene/Squalene Synthase Inhibitors: Leads for Innate Immune System-Based TherapeuticsBiochemical and Structural Basis for Inhibition of Enterococcus faecalis Hydroxymethylglutaryl-CoA Synthase, mvaS, by HymeglusinEnzymes of the mevalonate pathway of isoprenoid biosynthesisEnterococcus faecalis acetoacetyl-coenzyme A thiolase/3-hydroxy-3-methylglutaryl-coenzyme A reductase, a dual-function protein of isopentenyl diphosphate biosynthesis.Enterococcus faecalis 3-hydroxy-3-methylglutaryl coenzyme A synthase, an enzyme of isopentenyl diphosphate biosynthesis.Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus.Overexpressing 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) in the lactococcal mevalonate pathway for heterologous plant sesquiterpene productionNovel targets for the future development of antibacterial agents.Inhibition of bacterial mevalonate diphosphate decarboxylase by eriochrome compoundsEffect of levels of acetate on the mevalonate pathway of Borrelia burgdorferiExploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agentThe Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease.Is There Potential for Repurposing Statins as Novel Antimicrobials?Convergent strategies in biosynthesis.The increasingly complex mechanism of HMG-CoA reductase.A critical role of mevalonate for peptidoglycan synthesis in Staphylococcus aureus.Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.Enterococcus faecalis mevalonate kinase.The mevalonate pathway of Staphylococcus aureus.The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion.Effect of HMG-CoA reductase inhibitors on antimicrobial susceptibilities for gram-negative rods.Staphylococcus aureus 3-hydroxy-3-methylglutaryl-CoA synthase: crystal structure and mechanism.
P2860
Q21143865-CA4BFAD6-978B-4FB6-B6F0-A41B996CD383Q24631239-7C9947AF-88AC-4E4E-ADD7-08AC21A8CBFDQ27347664-7ABC06EB-508B-4CEB-9BA2-1CE0BA60A1B1Q27640636-3597BCEA-A8C4-428F-A329-F1592BA732E2Q27676950-8E0931E6-1626-4EBE-9D96-90A83793B7E8Q27678574-5971941F-B91A-4F42-BFC1-5EE2868F8584Q34142554-DCD3A0FC-DE5F-4108-B1BB-67682899A9E5Q34309106-97E2AF47-E120-45DF-9CC6-D2A9BEF2B37DQ34315780-36229400-733F-4375-8105-AC0AAC6D681BQ34434116-EC22D1A2-A694-4AF2-872D-4D4EDD660B3FQ34540711-C6990DD5-FC66-4914-8CE3-60A7B47822C0Q34631428-A9123B95-B586-41FD-AEBE-C3A5D05D0D1BQ35513007-D85C7A0F-0D4A-4010-9E93-8263BAC4B6BBQ36000800-49826EAF-ED91-4222-8793-3A7DE585BE24Q36265781-59F83913-BB51-4D0F-88EB-5DE769DCF8A5Q37107614-4C99C3DE-D565-49C7-9C5B-651161A19D96Q37156619-B9DFEA5E-82E6-498A-BF1E-C61770E7506EQ37203857-76692D0D-DD56-4E52-A450-E9FA1BBB5B30Q37872624-D4615AA4-94FC-4BF9-847F-857715B2F7A5Q38125222-5B06DC24-E2C1-494F-B006-DE5E3081C971Q38981904-0F1AAAA8-649F-441D-A835-85EDB315EA9BQ41771875-83103CC8-844B-459A-BC27-7F0DF9658165Q41815229-45C6C5C6-8CC7-4046-B29C-494864B353AFQ41857109-4E004606-3536-46DB-BC74-0C9B1FFD78E7Q42213030-0FABF7F5-7AD9-4B16-A65D-7B2D47759D47Q44304870-ADF287D3-31FA-4F26-97AA-DB242634138CQ45005948-F5F6EBF1-5707-476F-96F4-731CD82DACD4
P2860
Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@ast
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@en
type
label
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@ast
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@en
prefLabel
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@ast
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@en
P2093
P2860
P1476
Essentiality, expression, and ...... tase of Staphylococcus aureus.
@en
P2093
A P Bryant
C V Stauffacher
D McDevitt
D Sylvester
E I Wilding
M Rosenberg
R D Lunsford
P2860
P304
P356
10.1128/JB.182.18.5147-5152.2000
P407
P577
2000-09-01T00:00:00Z